Pulmonary infiltrates and skin pigmentation associated with sulfasalazine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1359782.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A patient with ulcerative colitis developed skin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology, while taking sulfasalazine. The clinical picture and radiological abnormalities disappeared spontaneously on discontinuation of the drug. Histopathological studies from specimens taken by transbronchial biopsy showed bronchiolitis obliterans with fibrosing alveolitis. Sulfasalazine-induced lung disorder is an extremely rare entity which must be considered in all ulcerative colitis patients while on sulfasalazine therapy, despite the absence of pulmonary symptomatology.
Medical subject headings
- Bronchiolitis Obliterans
- Drug Eruptions
- Pigmentation Disorders
- Pulmonary Fibrosis
- Skin Pigmentation
- Sulfasalazine